Global Value, Access and Commercialization Director – Regenerative Medicines

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner.

We are currently seeking a dynamic, highly motivated, and experienced individual for the position of Global Value and Access Director – Regenerative Medicine. This individual will lead execution of market access, pricing, and reimbursement plans across global markets outside the US for regenerative medicine assets, while providing strategic input into the central global access strategy, value framework, and pricing guardrails. This role will partner with the Senior Director, Global Commercial and Market Access Strategy on OUS access strategy, evidence and value planning, cross-functional launch readiness, and early payer/access considerations across priority markets.

This individual will work with the global cross‑functional team and external partners to ensure that access, reimbursement, and value considerations are embedded early and operationalized effectively.

• Lead development and execution of OUS market access, pricing, and reimbursement strategies across priority OUS markets, aligned with centrally defined global strategy
• Translate overall global strategic objectives into actionable OUS launch plan including the market access work streams, milestones, and deliverables aligned with global timelines
• Own and drive day‑to‑day execution of OUS market access priorities across assets, ensuring alignment to central strategy, timelines, and long‑range plans
• Drive OUS launch readiness activities related to access pathways, reimbursement planning, and pricing implementation
• Identify market‑specific access risks, reimbursement barriers, policy constraints, and operational dependencies that may impact OUS launch readiness or uptake
• Contribute to long‑range planning for international access, including launch sequencing assumptions, affordability considerations, and stakeholder engagement priorities
• Provide structured ex‑US market insights to inform global access strategy, evidence planning, and value narrative development

• Lead HTA planning and execution across priority markets, including EU JCA and relevant country‑level reimbursement pathways
• Develop country‑level pricing and reimbursement recommendations aligned with centrally defined pricing guardrails
• Support pricing and reimbursement negotiations in partnership with regional stakeholders, affiliates, and external partners as applicable
• Monitor international pricing, reimbursement, and policy developments—including reference pricing and analogous cross‑market risks—and recommend mitigation strategies
• Represent ex‑US access perspectives in cross‑functional planning and governance forums, escalating key trade‑offs and recommendations as appropriate
• Accountable for OUS access outcomes, including HTA success, reimbursement readiness, pricing alignment, and time to market access

You are a highly motivated, engaging and team‑oriented individual with a passion for problem solving and supporting clinicians and patients. You can lead without authority and organize impactful business meetings with the intent to develop and execute our strategy.

• Bachelor’s degree required; advanced degree preferred (e.g., MBA, MPH, PharmD, PhD, MS, or equivalent)
• 10+ years of progressive business experience in the healthcare, pharma or biotech industry, inclusive of global market access, pricing & reimbursement, value strategy, HEOR interface, or global commercial strategy; experience in cell, gene, and regenerative medicines a plus
• Experience with EU markets and country‑level HTAs, pricing and reimbursement; JCA experience preferred
• Strong understanding of payer, reimbursement, HTA, and access dynamics in OUS settings
• Ability to synthesize clinical,…